Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NAMI-A is a ruthenium-based compound with selective activity against tumor metastasis.NAMI-A inhibits cancer cell adhesion and migration.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 122.00 | |
10 mg | In stock | $ 172.00 | |
25 mg | In stock | $ 373.00 | |
50 mg | In stock | $ 686.00 | |
100 mg | In stock | $ 987.00 |
Description | NAMI-A is a ruthenium-based compound with selective activity against tumor metastasis.NAMI-A inhibits cancer cell adhesion and migration. |
In vitro |
NAMI-A can significantly affect tumor cells with metastatic ability. The half-life of NAMI-A elimination from the lungs is longer than for the liver, kidney, and primary tumor. NAMI-A bound to collagen is active on tumor cells as shown in vitro by an invasion test, using a modified Boyden chamber and Matrigel, and it inhibits the matrix metallo-proteinases MMP-2 and MMP-9 at micromolar concentrations.[1] The ruthenium drug NAMI-A inhibits the adhesion and migration of colorectal cancer cells. NAMI-A decreases α5β1 integrin expression and FAK auto-phosphorylation on Tyr 397.[2] |
Molecular Weight | 458.18 |
Formula | C8H15Cl4N4ORuS |
CAS No. | 201653-76-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 8.28 mg/mL (18.07 mM), Sonification and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NAMI-A 201653-76-1 Angiogenesis Cytoskeletal Signaling Metabolism Tyrosine Kinase/Adaptors FAK CETP NAMIA NAMI A inhibitor inhibit